Quality

Characteristics

Molar mass 441.51

CAS RN [106114-42-5]

Purity ≥ 95 %

• Colorless solid

Certificates

CoA: appearance, ¹H and ¹⁹F NMR spectra

Literature

Moerlein S.M. et al. Effect of Lipophilicity on the in Vivo Localization of Radiolabelled spiperone Analogues Int. J. Nucl. Med. Biol. 1985, 12, 353–356.

Chi D.Y. et al. Synthesis of no carrier added N-(3-[¹⁸F]fluoroalkyl)-spiperone derivatives. Appl. Radiat. Isot. 1986, 37, 1173–1180.

Coenen H.H. et al. 3-N-(2-[¹⁸F]Fluorethyl)-spiperone: A novel ligand for cerebral dopamine receptor studies with PET Life Sciences 1987, 40, 81–88.

Satyamurthy N. et al. 3-(2'[¹⁸F]Fluorethyl)spiperone, a Potent Dopamine Antagonist: Synthesis, Structural Analysis and In-vivo Utilization in Humans Int. J. Rad. Appl. Instrum. A 1990, 41, 113–129.

Hamacher K. et al. Remote controlled one-step production of ¹⁸F-labeled butyrophenone neuroleptics exemplified by the synthesis of n.c.a. [¹⁸F]N-methylspiperone. Appl. Radiat. Isot. 1995, 46, 911–916.